Publicly-listed Cytos Biotechnology Ltd has announced plans to merge with privately-owned Kuros Biosurgery Holding AG to create a new Switzerland-listed company that will be controlled by Kuros’ shareholders. ---Subscribe to MedNous to access this article--- Company News
